-
Antibody/Gene Therapy Biotech Gains $138 Million in Early Funds
A developer of synthetic antibodies for neurodegenerative disorders delivered like gene therapies is raising €129 million ($US 138 million) in its first venture funding round.
-
Infographic – Digital Health Funding Continues Slide
Venture funding for digital health start-ups continued heading down in the third quarter of 2023, reaching low levels not seen in almost a decade.
-
Peanut Allergy Toothpaste Shown Safe in Trial
Results of a clinical trial show a peanut allergy treatment formulated as a toothpaste can safely deliver immunotherapy to raise recipients’ peanut tolerance.
-
Challenge Seeks Transformative Human/A.I. Research Tech
A new challenge competition with $1 million in prizes seeks novel techniques for conducting biomedical research with data on human physiology and artificial intelligence.
-
Life Science Incubator Gains $100M in Start-Up Funds
A new-business accelerator program, begun earlier this year to advance and commercialize biomedical research discoveries from academic labs, is receiving a $100 million founding grant.
-
Home V.R. Therapy Shown to Reduce Back Pain
A virtual reality program conducted at home is shown in a clinical trial to relieve chronic lower back pain intensity and improve daily living more than a sham V.R. program.
-
Electric Pulses Induce Lung Cancer Immune Response
Results of a clinical trial show a lung cancer therapy using highly focused pulses with electrical energy show signs of immune responses that can treat the patients’ tumors.
-
Keeping Conversations Positive with Precision Moderation
Sponsored content removed due to non-payment.
-
Taking a Break
We will resume our editorial posts on Monday 6 Nov. 2023.
-
Infographic – Little Trust in Companies’ A.I. Use
A poll in the U.S. shows a large majority of Americans who heard of artificial intelligence have very little or no trust that companies will use the technology responsibly.